{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T04:08:50Z","timestamp":1780805330919,"version":"3.54.1"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2015,4,2]],"date-time":"2015-04-02T00:00:00Z","timestamp":1427932800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0121984","type":"journal-article","created":{"date-parts":[[2015,4,2]],"date-time":"2015-04-02T17:58:46Z","timestamp":1427997526000},"page":"e0121984","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["No Impact of Vitamin D on the CYP3A Biomarker 4\u03b2-Hydroxycholesterol in Patients with Abnormal Glucose Regulation"],"prefix":"10.1371","volume":"10","clinical-trial-number":[{"clinical-trial-number":"nct01497132","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Buster","family":"Mannheimer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claes-G\u00f6ran","family":"\u00d6stenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Diczfalusy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,4,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s002280050420","article-title":"The area under the plasma concentration-time curve for oral midazolam is 400-fold larger during treatment with itraconazole than with rifampicin","volume":"54","author":"JT Backman","year":"1998","journal-title":"Eur J Clin Pharmacol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1124\/dmd.113.051136","article-title":"Serum levels of 25-hydroxyvitamin D and the CYP3A biomarker 4beta-hydroxycholesterol in a high-dose vitamin D supplementation study","volume":"41","author":"L Bjorkhem-Bergman","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"38685","DOI":"10.1074\/jbc.M105127200","article-title":"Antiepileptic drugs increase plasma levels of 4beta-hydroxycholesterol in humans: evidence for involvement of cytochrome p450 3A4","volume":"276","author":"K Bodin","year":"2001","journal-title":"J Biol Chem"},{"key":"ref4","first-page":"E214","article-title":"Glucose clamp technique: a method for quantifying insulin secretion and resistance","volume":"237","author":"RA DeFronzo","year":"1979","journal-title":"Am J Physiol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/FPC.0b013e3282f50ee9","article-title":"4Beta-hydroxycholesterol is a new endogenous CYP3A marker: relationship to CYP3A5 genotype, quinine 3-hydroxylation and sex in Koreans, Swedes and Tanzanians","volume":"18","author":"U Diczfalusy","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2125.2010.03773.x","article-title":"4beta-Hydroxycholesterol, an endogenous marker of CYP3A4\/5 activity in humans","volume":"71","author":"U Diczfalusy","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1476-5381.2011.01270.x","article-title":"Significantly reduced cytochrome P450 3A4 expression and activity in liver from humans with diabetes mellitus","volume":"163","author":"M Dostalek","year":"2011","journal-title":"Br J Pharmacol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/85417","article-title":"CYP3A genetics in drug metabolism","volume":"7","author":"M Eichelbaum","year":"2001","journal-title":"Nat Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1464-5491.2008.02463.x","article-title":"Psychological distress and risk of pre-diabetes and Type 2 diabetes in a prospective study of Swedish middle-aged men and women","volume":"25","author":"AK Eriksson","year":"2008","journal-title":"Diabet Med"},{"key":"ref10","article-title":"Drug interactions: Cytochrome P450 Drug Interaction Table","author":"D Flockhart","year":"2007"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1053\/jhep.2003.50176","article-title":"The normal liver harbors the vitamin D nuclear receptor in nonparenchymal and biliary epithelial cells","volume":"37","author":"M Gascon-Barre","year":"2003","journal-title":"Hepatology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0009-9236(98)90146-1","article-title":"The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin","volume":"64","author":"JC Gorski","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1210\/me.2009-0482","article-title":"A novel bile acid-activated vitamin D receptor signaling in human hepatocytes","volume":"24","author":"S Han","year":"2010","journal-title":"Mol Endocrinol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/clpt.2008.132","article-title":"Cytochrome P450 induction by rifampicin in healthy subjects: determination using the Karolinska cocktail and the endogenous CYP3A4 marker 4beta-hydroxycholesterol","volume":"84","author":"KP Kanebratt","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0009-9236(98)90023-6","article-title":"Effect of itraconazole on the pharmacokinetics of atorvastatin","volume":"64","author":"T Kantola","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0009-9236(98)90151-5","article-title":"Erythromycin and verapamil considerably increase serum simvastatin and simvastatin acid concentrations","volume":"64","author":"T Kantola","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejps.2009.01.006","article-title":"Comparison of effects of VDR versus PXR, FXR and GR ligands on the regulation of CYP3A isozymes in rat and human intestine and liver","volume":"37","author":"AA Khan","year":"2009","journal-title":"Eur J Pharm Sci"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1124\/dmd.111.038125","article-title":"Seasonal variation in blood drug concentrations and a potential relationship to vitamin D","volume":"39","author":"JD Lindh","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0090-9556(25)08440-5","article-title":"Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test","volume":"22","author":"KS Lown","year":"1994","journal-title":"Drug Metab Dispos"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"709","DOI":"10.5414\/CPP47709","article-title":"4beta-hydroxycholesterol as a marker of CYP3A4 inhibition in vivo\u2014effects of itraconazole in man","volume":"47","author":"D Lutjohann","year":"2009","journal-title":"Int J Clin Pharmacol Ther"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Nylen H, Bjorkhem-Bergman L, Ekstrom L, Roh HK, Bertilsson L, Eliasson E, et al. Plasma Levels of 25-Hydroxyvitamin D and In Vivo Markers of Cytochrome P450 3A Activity in Swedes and Koreans: Effects of a Genetic Polymorphism and Oral Contraceptives. Basic Clin Pharmacol Toxicol. 2014.","DOI":"10.1111\/bcpt.12230"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/00008571-200007000-00001","article-title":"Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method","volume":"10","author":"V Ozdemir","year":"2000","journal-title":"Pharmacogenetics"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/S0022-3565(24)37149-6","article-title":"Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism","volume":"283","author":"MF Paine","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1124\/dmd.104.002469","article-title":"Do men and women differ in proximal small intestinal CYP3A or P-glycoprotein expression?","volume":"33","author":"MF Paine","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.bcp.2009.08.017","article-title":"Intestinal cell-specific vitamin D receptor (VDR)-mediated transcriptional regulation of CYP3A4 gene","volume":"79","author":"P Pavek","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1365-2125.2005.02529.x","article-title":"Clinically relevant drug interactions with antiepileptic drugs","volume":"61","author":"E Perucca","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1124\/mol.51.5.741","article-title":"Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1alpha,25-dihydroxyvitamin D3","volume":"51","author":"P Schmiedlin-Ren","year":"1997","journal-title":"Mol Pharmacol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/clpt.2008.165","article-title":"Effects of vitamin D supplementation in atorvastatin-treated patients: a new drug interaction with an unexpected consequence","volume":"85","author":"JB Schwartz","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1124\/dmd.113.054171","article-title":"Association of plasma concentration of 4beta-hydroxycholesterol with CYP3A5 polymorphism and plasma concentration of indoxyl sulfate in stable kidney transplant recipients","volume":"42","author":"Y Suzuki","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.bcp.2012.03.017","article-title":"Intestinal CYP3A4 and midazolam disposition in vivo associate with VDR polymorphisms and show seasonal variation","volume":"84","author":"RK Thirumaran","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0006-291X(02)02742-0","article-title":"Liganded VDR induces CYP3A4 in small intestinal and colon cancer cells via DR3 and ER6 vitamin D responsive elements","volume":"299","author":"PD Thompson","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1124\/mol.60.6.1399","article-title":"Transcriptional control of intestinal cytochrome P-4503A by 1alpha,25-dihydroxy vitamin D3","volume":"60","author":"KE Thummel","year":"2001","journal-title":"Mol Pharmacol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0009-9236(96)90177-0","article-title":"Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism","volume":"59","author":"KE Thummel","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1172\/JCI113156","article-title":"Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man","volume":"80","author":"PB Watkins","year":"1987","journal-title":"J Clin Invest"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1365-2125.2007.03078.x","article-title":"Time course of the increase in 4beta-hydroxycholesterol concentration during carbamazepine treatment of paediatric patients with epilepsy","volume":"65","author":"K Wide","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1124\/dmd.104.000794","article-title":"Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi\/AUC) ratios","volume":"32","author":"JA Williams","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.bcp.2006.04.033","article-title":"Selective induction of intestinal CYP3A23 by 1alpha,25-dihydroxyvitamin D3 in rats","volume":"72","author":"Y Xu","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1172\/JCI27793","article-title":"Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia","volume":"116","author":"C Zhou","year":"2006","journal-title":"J Clin Invest"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0121984","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T20:59:31Z","timestamp":1747861171000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0121984"}},"subtitle":[],"editor":[{"given":"Yiqing","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,4,2]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,4,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0121984","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,2]]}}}